Compare DRTS & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | LAES |
|---|---|---|
| Founded | 2015 | 2022 |
| Country | Israel | Switzerland |
| Employees | 121 | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 641.6M | 606.5M |
| IPO Year | N/A | 2022 |
| Metric | DRTS | LAES |
|---|---|---|
| Price | $7.52 | $2.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $8.67 | $4.00 |
| AVG Volume (30 Days) | 330.6K | ★ 12.1M |
| Earning Date | 05-18-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $93.36 |
| Revenue Next Year | $699.98 | $43.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.59 | $1.99 |
| 52 Week High | $8.80 | $8.71 |
| Indicator | DRTS | LAES |
|---|---|---|
| Relative Strength Index (RSI) | 48.11 | 54.04 |
| Support Level | $6.47 | $2.54 |
| Resistance Level | $7.75 | $3.28 |
| Average True Range (ATR) | 0.56 | 0.23 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 19.00 | 57.18 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.